Previous Close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.1000 |
Strike | 2.50 |
Expire Date | 2024-07-19 |
Day's Range | 0.0500 - 0.0500 |
Contract Range | N/A |
Volume | |
Open Interest | 125 |
Enzo Biochem's (ENZ) overall topline benefits from revenue growth in the majority of its geographic regions.
FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2024. Third Quarter Highlights The Company's Life Science division's third-quarter revenue of $8.0 million improved year-over-year by 7%, marking four consecutive quarters of revenue growth compared to the prior year quarterly periods. Revenue for the nine months ended April 30, 2024 of $24.4 million improved
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...